SLGL
SLGL
NASDAQ · Pharmaceuticals

Sol-Gel Technologies Ltd

$70.02
+0.48 (+0.69%)
As of May 8, 3:55 PM ET ·
Financial Highlights (FY 2026)
Revenue
22.05M
Net Income
-6,967,411
Gross Margin
Profit Margin
-31.6%
Rev Growth
+71.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 29.4% 29.4%
Operating Margin -38.9% -35.0% 42.3% 41.5%
Profit Margin -31.6% -30.0% 33.8% 28.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 22.05M 12.90M 80.43M 74.82M
Gross Profit 23.62M 21.97M
Operating Income -8,572,057 -4,512,664 34.02M 31.02M
Net Income -6,967,411 -3,667,916 27.17M 21.09M
Gross Margin 29.4% 29.4%
Operating Margin -38.9% -35.0% 42.3% 41.5%
Profit Margin -31.6% -30.0% 33.8% 28.2%
Rev Growth +71.0% +71.0% -4.6% -5.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 45.73M 50.34M
Total Equity 128.24M 118.27M
D/E Ratio 0.36 0.43
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,448,141 -4,694,509 38.14M 36.98M
Free Cash Flow 15.33M 13.15M